Assembly Biosciences Gets $30.1M Equity Investment, Funding

Gilead raises Assembly Bio stake to ~30%
Shares of Assembly Biosciences (NASDAQ:ASMB) traded higher on Thursday after Gilead Sciences (NASDAQ:GILD) agreed to increase its ownership in the antiviral developer to 29.9% following an equity investment of $20.
Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead
Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional Assembly Bio stock, with an amendment to their collaboration with Assembly to ...
Gilead invests in Assembly Bio to advance clinical programs
US biotech Assembly Biosciences has announced an equity investment of $20.1 million by Gilead Sciences to purchase additional common stock in the company and an amendment to their collaboration to advance the research and development of novel antiviral therapies with $10 million in accelerated funding.
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
Dec. 19, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced ...
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding
Assembly Biosciences shares were up 19% at $16.01 after receiving an equity investment and accelerated funding from Gilead Sciences. Shares of the biotechnology company hit a 52-week high of $19.93 on Sept. 23, and are up 75% in the past 12 months.
Business Insider4d
Assembly Biosciences announces $30.1M investment, funding from Gilead
Assembly Biosciences (ASMB) announced an equity investment of $20.1M by Gilead Sciences (GILD) to purchase additional Assembly Bio common stock and an amendment to their collaboration to advance ...
Morningstar4d
Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead
Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional Assembly Bio ...